Apple Mandates Medical Device App Disclosures in Key Markets
Apple Inc. has announced new requirements for app developers in the European Economic Area (EEA), United Kingdom, and United States, mandating that apps classified as regulated medical devices display their status on App Store product pages, according to an official statement published on October 10, 2023.
What are the criteria for regulated medical device apps?
Regulated medical device apps, as defined by Apple, are those that function independently or as part of a system for medical purposes such as diagnosis, prevention, monitoring, or treatment of diseases and physiological conditions. These apps may require registration or authorization from regulatory bodies like the U.S. Food and Drug Administration (FDA), according to Apple’s App Store Connect documentation.
Developers must declare a regulated medical device status if their app falls into either of two categories:
- Primary or secondary category is Health & Fitness or Medical
- Marked as containing frequent references to Medical or Treatment Information in the Age Rating questionnaire in App Store Connect
When do developers need to comply?
New apps meeting the criteria must include the regulated medical device status starting immediately, while existing apps distributed in the EEA, UK, or U.S. must comply by early 2027, according to Apple’s official guidelines. Failure to declare an app’s status by this deadline will result in the inability to submit app updates, as outlined in the company’s developer documentation.
Why is Apple making this change?
The update aligns with broader regulatory trends emphasizing transparency in digital health tools. The FDA has previously emphasized the importance of clear labeling for medical apps, stating that “users must have access to accurate information about an app’s intended use and regulatory status,” according to a 2022 agency report. Apple’s move reflects growing scrutiny of health-related software, particularly as wearable and mobile health technologies become more integrated into clinical care.
What are the implications for developers?
Developers must now provide regulatory information, including contact details and safety data, through App Store Connect. This adds administrative complexity, particularly for smaller companies unfamiliar with medical device compliance protocols. However, Apple has provided a “No” option for apps not classified as regulated medical devices, according to its official guidelines.
How does this compare to other platforms?
Google Play Store’s policies for medical apps differ slightly. While it requires developers to disclose health-related functionality, it does not mandate the same level of regulatory transparency as Apple’s new requirements. This divergence highlights varying approaches among tech giants to balancing user safety and developer flexibility, according to a 2023 analysis by *The Verge*.
What happens if developers don’t comply?
Apps that fail to meet the new standards will be restricted from receiving updates after early 2027, effectively freezing their functionality unless developers address the compliance gap. This could impact user access to critical health tools, particularly in regions with limited healthcare infrastructure, according to a statement from the Digital Health Coalition, a non-profit advocacy group.
Apple’s policy underscores the increasing regulatory oversight of digital health technologies, with implications for both developers and end-users. As the company continues to refine its app review processes, stakeholders will need to navigate evolving compliance requirements to maintain access to essential health services.